CAR-NK92 cells transduced with an anti-B7-H3 CAR exhibited strong cytotoxicity against melanoma cells independently of NKG2A expression or knockout, suggesting that anti-B7-H3 CAR-NK92 cells had displayed resistance towards NK inhibitory signaling mechanisms that are believed to underlie tumoral immune evasion [164]. This evidence concerns the gene CD276 and melanoma.